SCLEROSOL Drug Patent Profile
✉ Email this page to a colleague
When do Sclerosol patents expire, and what generic alternatives are available?
Sclerosol is a drug marketed by Sciarra Labs and is included in one NDA.
The generic ingredient in SCLEROSOL is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sclerosol
A generic version of SCLEROSOL was approved as talc by SCIARRA LABS on December 15th, 2003.
Summary for SCLEROSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 291 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in SCLEROSOL? | SCLEROSOL excipients list |
| DailyMed Link: | SCLEROSOL at DailyMed |
US Patents and Regulatory Information for SCLEROSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciarra Labs | SCLEROSOL | talc | AEROSOL;INTRAPLEURAL | 020587-001 | Dec 24, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
